Agios Pharmaceuticals initiated with a Buy at H.C. Wainwright
H.C. Wainwright initiated coverage of Agios Pharmaceuticals (AGIO) with a Buy rating and $58 price target The firm views the company’s lead ...
Benitec Biopharma’s (BNTC) “Buy” Rating Reiterated at HC Wainwright
HC Wainwright reissued their buy rating on shares of Benitec Biopharma (NASDAQ:BNTC – Free Report) in a research report sent ...
Ardelyx’s (ARDX) Neutral Rating Reiterated at HC Wainwright
HC Wainwright reiterated their neutral rating on shares of Ardelyx (NASDAQ:ARDX – Free Report) in a research report sent to ...